Description
Molecular Targeting of Human Acute Myeloid Leukemia and Bone Marrow Regeneration
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-07-01$4,162,215
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-07-01(start date) | $4,162,215 | — | Molecular Targeting of Human Acute Myeloid Leukemia and Bone Marrow Regeneration |
Related records · 4
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2025-2026-Q2-00508 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,441,235 | FY2026 |
| 236-2025-2026-Q1-01069 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,239,109 | FY2026 |
| 236-2017-2018-Q1-00796 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $1,040,400 | FY2018 |
| 236-2015-2016-Q2-00666 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $800,972 | FY2016 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2018-2019-Q2-00388 · retrieved 2026-11-13.